# Anti-Carbamylated Protein Antibodies in Psoriatic Arthritis

> **NCT04173039** · NA · COMPLETED · sponsor: **Association pour la Recherche Clinique et Immunologique** · enrollment: 300 (actual)

## Conditions studied

- Psoriasis
- Arthritis, Psoriatic

## Interventions

- **DIAGNOSTIC_TEST:** Serum anti-CarP antibodies detection

## Key facts

- **NCT ID:** NCT04173039
- **Lead sponsor:** Association pour la Recherche Clinique et Immunologique
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-29
- **Primary completion:** 2019-04-24
- **Final completion:** 2019-04-24
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2019-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04173039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04173039, "Anti-Carbamylated Protein Antibodies in Psoriatic Arthritis". Retrieved via AI Analytics 2026-09-14 from https://api.ai-analytics.org/clinical/NCT04173039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*